Skip to main content

Security report for muller-pharma.cz

Dr. Müller Pharma s.r.o. · Healthcare · Czech Republic

High risk. 10 critical or high findings in GDPR outside view, Network security and 2 other checks.

Security score

45/100

Risk levelHigh

0–100, higher is better. How it is calculated

Dr. Müller Pharma s.r.o. is a prominent Czech manufacturer specializing in pharmaceuticals, medical devices, cosmetics, and dietary supplements. The company maintains a professional online presence with a well-structured website offering product information and an e-commerce platform. Their market position is strong within the Czech healthcare sector, targeting general consumers and healthcare professionals. The website demonstrates consistent branding and provides essential business information, including company registration details and social media links. From a technical perspective, the website employs standard web technologies such as jQuery and Google reCAPTCHA, ensuring basic security and user interaction features. The site is mobile-optimized and includes cookie consent mechanisms aligned with GDPR requirements. However, there is room for improvement in accessibility and security headers implementation to enhance overall resilience. Security posture is adequate with HTTPS enforced and consent management in place, but the absence of explicit security policies, incident response contacts, and vulnerability disclosure mechanisms indicates a moderate maturity level. The missing WHOIS data for the domain is a notable concern, potentially impacting trustworthiness and legitimacy perceptions. Overall, the website is functional, professional, and compliant with privacy norms but would benefit from enhanced transparency in security practices and verification of domain registration details to strengthen stakeholder confidence.

Scanned

NIS2 and GDPR posture

GDPR outside view
25/ 100 · Critical
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

10 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      EU business without adequate privacy measures

      EU businesses are subject to strict GDPR requirements

      What to do: Implement comprehensive GDPR compliance including privacy policy, cookie consent, and data protection measures

  2. Network security

    Services reachable from the internet are the first thing attackers probe. Anything open that does not need to be should be closed.

    • Critical

      Critical Service Exposed: MySQL

      Port 3306 (MySQL) is publicly accessible - MySQL - Database server

      What to do: Immediately restrict access to MySQL using firewall or VPN

      • NIS2 21(2)(e)
      • IR 2024/2690 6.7.2(f): Implementing Regulation (EU) 2024/2690, Annex point 6.7.2(f): Network security
      • NIST CM-7: NIST SP 800-53 Rev. 5 CM-7: Least Functionality
      • NIST SC-7: NIST SP 800-53 Rev. 5 SC-7: Boundary Protection
  3. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

Need hands-on remediation? Email guard@offseq.com

Keep watching muller-pharma.cz

This scan found 26 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
72
Security headers
25
Email security
70
DNS health
75
Network security
0
GDPR outside view
25
Average
45

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet · found on this site
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The company operates primarily in the healthcare manufacturing sector, producing pharmaceuticals, medical devices, cosmetics, and dietary supplements. Their business model integrates manufacturing with direct-to-consumer sales via an e-shop, supported by a partner domain (avonizdravim.cz). The presence of social media channels and a cookie consent mechanism indicates awareness of digital marketing and privacy compliance. The company appears medium-sized with a focused market in the Czech Republic. The lack of detailed financial or founding year data limits deeper business intelligence insights. Partnerships with digital service providers like Digimadi suggest a collaborative ecosystem supporting their online presence.

Security posture

The website enforces HTTPS and uses Google reCAPTCHA to protect forms, which are positive security practices. Cookie consent is implemented with granular user controls, supporting GDPR compliance. However, no security headers such as Content Security Policy, HSTS, or X-Frame-Options were detected, which are recommended to mitigate common web vulnerabilities. There is no published security policy or incident response information, reducing transparency and preparedness perception. The absence of a vulnerability disclosure program or security.txt file further limits proactive security engagement. Overall, the security posture is moderate but could be significantly improved with additional controls and transparency.

Recommendations

  1. Implement standard security headers including CSP, HSTS, X-Frame-Options, and X-XSS-Protection to enhance web security.
  2. Publish a clear security policy and incident response contact information on the website to improve transparency and trust.
  3. Establish a vulnerability disclosure program or security.txt file to encourage responsible reporting of security issues.
  4. Verify and update WHOIS domain registration information to ensure legitimacy and improve trustworthiness.
  5. Conduct regular security audits of third-party scripts and dependencies to prevent vulnerabilities.

Contact details published on the site

Addresses
Legal name
Dr. Müller Pharma s.r.o.
Registration number
632 18 976
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Dr. Müller Pharma s.r.o.
Description
Dr. Müller Pharma is a leading Czech manufacturer of pharmaceuticals, medical devices, cosmetics, and dietary supplements.
Key services
Pharmaceutical manufacturing, Medical devices production, Cosmetics manufacturing, Dietary supplements, E-commerce sales
Content quality
good
Branding
consistent

Technology

Stack
jQuery, jQuery UI, Google reCAPTCHA, Custom JavaScript, CSS3
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
80/100
Good practices seen
  • HTTPS enforced
  • Cookie consent with granular controls
  • Google reCAPTCHA on forms

Analytics and tracking

Services
Google Analytics
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Facebook SDK
Marketing tools
Facebook Pixel
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with no blocking or WAF challenges.
  2. WHOIS data is missing or unavailable, which is unusual and warrants further investigation.
  3. Cookie consent mechanism is implemented with granular user controls.
  4. No explicit security policy or incident response information is published.
  5. Company information is clearly presented in footer with registration details.
  6. Social media presence is active on Facebook and Instagram.
  7. Website uses standard web technologies and includes Google Analytics and Facebook tracking.
  8. No signs of adult or inappropriate content.
  9. No phone numbers or direct company emails found except webmaster email.
  10. Terms of service and privacy policy are present and linked.
Technical notes

Notes

The website uses a traditional tech stack centered around jQuery and jQuery UI, with custom JavaScript for UI interactions and cookie consent management. Google reCAPTCHA is integrated for form protection. The site loads CSS and JS resources from its own domain and a partner CDN (webseller-app.com). Performance is moderate with some large images but generally acceptable. Mobile optimization is good with responsive design elements. Accessibility is basic but could be improved with ARIA roles and better keyboard navigation support. SEO is supported by meta tags and Open Graph data, enhancing social sharing and search visibility. No modern frameworks (React, Angular, Vue) or CMS platforms were detected, indicating a custom or legacy build.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with muller-pharma.cz. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review muller-pharma.cz.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.